Holtz Ben-Ole, Grimm Alexander, Axer Hubertus
Department of Neurology Jena University Hospital Jena Germany.
Department of Neurology Tuebingen University Hospital Tuebingen Germany.
Health Sci Rep. 2021 Dec 21;4(4):e469. doi: 10.1002/hsr2.469. eCollection 2021 Dec.
Guillain Barré syndrome (GBS) could be triggered by an infectious disease but by vaccination as well. Thus, suffering GBS may influence patients' attitudes towards vaccination.
An anonymous questionnaire consisting of the Overall Neuropathy Limitations Score (ONLS), the short form-36 health survey (SF-36), and questions addressing patients' attitude towards vaccination was sent to members of a German GBS support group and to patients with GBS diagnosis who were treated at Jena University Hospital.
Ninety-seven questionnaires clearly stated GBS as a diagnosis and were included in the analysis. Although 19.6% of the GBS patients reported having no disability in the long-time follow-up, a considerable number of patients still had persistent neurological symptoms; 74.2% of the GBS patients reported being able to walk at least 10 m independently. However, 5.2% were restricted to wheelchair. The patients reached lower scores in all domains of quality of life compared to German controls. Moreover, patients showed a more critical attitude towards vaccination compared to a German representative survey. Fewer patients (58.8%) received a vaccination after suffering from GBS than before (77.3%). Every tenth patient believed that vaccination was the trigger for the GBS. 32% of the patients did not receive a vaccination in the last 5 years mainly because of the fear of adverse effects (32%) or disadvise of the general practitioners (25.8%).
Although the risk of relapse following immunization may be rather low, uncertainties and fears still impair the counseling of these patients by their medical practitioner.
吉兰 - 巴雷综合征(GBS)可由传染病引发,也可由疫苗接种引发。因此,患GBS可能会影响患者对疫苗接种的态度。
一份包含总体神经病变限制评分(ONLS)、简短健康调查问卷36项(SF - 36)以及关于患者对疫苗接种态度问题的匿名问卷,被发送给德国GBS支持小组的成员以及在耶拿大学医院接受治疗的GBS确诊患者。
97份问卷明确将GBS列为诊断结果并纳入分析。虽然19.6%的GBS患者报告在长期随访中无残疾,但仍有相当数量的患者存在持续性神经症状;74.2%的GBS患者报告能够独立行走至少10米。然而,5.2%的患者只能依赖轮椅。与德国对照组相比,这些患者在生活质量的所有领域得分都较低。此外,与德国的一项代表性调查相比,患者对疫苗接种表现出更为批判的态度。患GBS后接受疫苗接种的患者(58.8%)比患病前(77.3%)更少。每十位患者中有一位认为疫苗接种是GBS的诱因。32%的患者在过去5年未接种疫苗,主要原因是担心不良反应(32%)或全科医生的建议(25.8%)。
尽管免疫后复发的风险可能相当低,但不确定性和恐惧仍然妨碍了医生对这些患者的咨询。